Patent · US Active

Selective HDAC3 inhibitors

US9562013B2 · kind B2 · utility

7Cited by
6References
11Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 29, 2015
Grant dateFeb 7, 2017
Priority date—
Expiry dateJun 29, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D241/44
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided herein are HDAC3 inhibitors, as well as methods of treatment comprising administering these compounds to a subject in need thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.